HomeALPN • NASDAQ
Follow
Alpine Immune Sciences Inc
Previous close
$38.65
Day range
$37.94 - $38.92
Year range
$6.71 - $42.88
Market cap
2.51B USD
Avg Volume
1.19M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 30.85M | 1,011.42% |
Operating expense | 6.37M | 45.23% |
Net income | 5.96M | 131.59% |
Net profit margin | 19.32 | 102.84% |
Earnings per share | 0.15 | 136.59% |
EBITDA | 1.69M | 108.37% |
Effective tax rate | 1.70% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 327.41M | 37.78% |
Total assets | 379.85M | 32.50% |
Total liabilities | 51.91M | -51.61% |
Total equity | 327.94M | — |
Shares outstanding | 55.14M | — |
Price to book | 6.50 | — |
Return on assets | 1.25% | — |
Return on capital | 1.55% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 5.96M | 131.59% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2007
Headquarters
Website
Employees
142